Spero Therapeutics (2HA.F) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.49
-0.34
-0.18
-0.03

Details

Expected EPS
-0.214975
Actual EPS
-0.111787
Surprise EPS
0.1
Surprise Percent
+48%

Description

Spero Therapeutics (2HA.F) has reported earnings of -0.111787 per share for Q4 2025.

0 Comments

Share your thoughts